Compare Baxter International Inc (BAX) vs Credo Technology Group Holding Ltd (CRDO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Baxter International Inc vs Credo Technology Group Holding Ltd — how do they compare? Baxter International Inc trades at $27.61 (market cap $14.36B), while Credo Technology Group Holding Ltd trades at $256 (market cap $44.74B). The key difference: Credo Technology Group Holding Ltd is far larger — about 3.1× Baxter International Inc's market cap, and Baxter International Inc pays a 0.14% dividend while Credo Technology Group Holding Ltd pays none. Which is the better fit depends on your goals.
| BAX | CRDO | |
|---|---|---|
Market Cap | $14.36B | $44.74B |
Sector | Health | Technology |
52-Week High | $28.35 | $302.52 |
52-Week Low | $15.80 | $87.81 |
Enterprise Value | $21.88B | $43.32B |
Dividend Yield | 0.14% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
CRDO trades at $249.89, up 8.45% today, with strong technical momentum above key support at $237. The stock shows exceptional fundamental growth with revenue surging from $437M in 2025 to $1.3B projected for 2026, while maintaining robust 35.37% net margins. Recent news highlights Credo's strategic positioning in AI infrastructure through contributions to the Open Compute Project and institutional accumulation.
Outlook remains positive given accelerating AI capex and strong analyst consensus (86.7% buy ratings) with $285.42 price target. Key risks include premium valuation (P/E 95.6), customer concentration, and execution challenges in scaling operations amid competitive AI infrastructure landscape.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Baxter International Inc
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →About Credo Technology Group Holding Ltd
Credo Technology provides high-speed connectivity solutions for AI-driven applications and hyperscale data centers. Its products enable faster, more energy-efficient data transmission for cloud and telecom infrastructure.
Read more on CRDO →
